Graham Capital Management’s MacroGenics MGNX Stock Holding History

Graham Capital Management’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$219K	Buy	47,456 +36,334	+327%	+$137K	﹤0.01%	1007
2026 Q1	$32.1K	Buy	+11,122	New	+$23.7K	﹤0.01%	1107
2024 Q2	–	Sell	-31,663	Closed	-$466K	–	1238
2024 Q1	$466K	Buy	+31,663	New	+$479K	0.01%	646
2023 Q4	–	Sell	-18,332	Closed	-$85.4K	–	1196
2023 Q3	$85.4K	Sell	18,332 -3,095	-14%	-$15.4K	﹤0.01%	941
2023 Q2	$115K	Buy	+21,427	New	+$132K	﹤0.01%	880
2023 Q1	–	Sell	-32,451	Closed	-$218K	–	1226
2022 Q4	$218K	Sell	32,451 -172,899	-84%	-$948K	0.01%	958
2022 Q3	$710K	Sell	205,350 -158,943	-44%	-$608K	0.03%	626
2022 Q2	$1.07M	Buy	364,293 +298,978	+458%	+$1.57M	0.04%	414
2022 Q1	$575K	Buy	65,315 +54,546	+507%	+$602K	0.02%	507
2021 Q4	$172K	Buy	+10,769	New	+$203K	0.01%	483

Other funds holding MGNX

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Graham Capital Management's MGNX Position: Q2 2026 in Review

Graham Capital Management increased its MacroGenics (MGNX) stake by 327% in Q2 2026, buying an estimated $137K and bringing the position to 47,456 shares worth $219K. The position accounts for ﹤0.01% of the portfolio, ranked #1007.

Graham Capital Management first reported a position in MGNX in Q4 2021 and has held it in 10 quarters since. The position peaked at $1.07M in Q2 2022. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

Graham Capital Management held 47,456 shares of MacroGenics worth $219K as of Q2 2026.
Graham Capital Management bought 36,334 MacroGenics shares in Q2 2026, an estimated $137K.
MacroGenics made up ﹤0.01% of Graham Capital Management's portfolio in Q2 2026, its #1007 holding.
Graham Capital Management first reported a position in MacroGenics in Q4 2021 and has held it in 10 quarters since.
Graham Capital Management's MacroGenics position peaked at $1.07M in Q2 2022.
122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.